|
|
Aspira Biosystems is developing technology that enables
the capture, with very high specificity, of targeted proteins. Aspira is
actively seeking academic and commercial partners to develop therapeutic,
medical research and industrial applications based on Partial Molecular
Imprinting (PMI), our
patented protein capture platform.
|
|
|
